rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Andrew R. Neill

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Shattuck Labs.

In numbers

Trades disclosed
37
Buys
0
Sells
6
Bought
$0
Sold
$1.8M
Companies
1
Companies where not an officer
0
First trade
5 Nov 2020
Last trade
12 May 2026
Last filed
14 May 2026

Companies traded

Where they are an officer
STTK Shattuck LabsOfficer · Biotechnology · last 12 May 20260 buys · 6 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 May 2026filed 14 May 2026STTK Shattuck LabsBiotechnologySEC FORM 4 Code A$69K64,027 at $1.08filing
12 May 2026filed 14 May 2026STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code M—64,027filing
12 May 2026filed 14 May 2026STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code M—64,027filing
12 May 2026filed 14 May 2026STTK Shattuck LabsBiotechnologySEC FORM 4 Code A$69K64,027 at $1.08filing
25 Jan 2026filed 27 Jan 2026STTK Shattuck LabsBiotechnologySEC FORM 4 Code F$11K2,589 at $4.15filing
25 Jan 2026filed 27 Jan 2026STTK Shattuck LabsBiotechnologySEC FORM 4 Code F$11K2,589 at $4.15filing
10 Jan 2026filed 13 Jan 2026STTK Shattuck LabsBiotechnologySEC FORM 4 Code F$32K6,660 at $4.75filing
10 Jan 2026filed 13 Jan 2026STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—549,800 at $0.00filing
10 Jan 2026filed 13 Jan 2026STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—549,800 at $0.00filing
10 Jan 2026filed 13 Jan 2026STTK Shattuck LabsBiotechnologySEC FORM 4 Code F$32K6,660 at $4.75filing
25 Aug 2025filed 27 Aug 2025STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—64,027filing
25 Aug 2025filed 27 Aug 2025STTK Shattuck LabsBiotechnologySEC FORM 4 Code A$56K64,027 at $0.87filing
28 Jan 2025filed 28 Jan 2025STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—214,000 at $0.00filing
10 Jan 2024filed 16 Jan 2024STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—113,000 at $0.00filing
10 Jan 2024filed 16 Jan 2024STTK Shattuck LabsBiotechnologySEC FORM 4 Code A—56,500 at $0.00filing
10 Jan 2024filed 16 Jan 2024STTK Shattuck LabsBiotechnologySEC FORM 4 Code F$25K2,470 at $10.09filing
10 Jan 2024filed 16 Jan 2024STTK Shattuck LabsBiotechnologySEC FORM 4 Sold$250K25,000 at $10.00filing
25 Jan 2023filed 27 Jan 2023STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—69,850 at $0.00filing
25 Jan 2023filed 27 Jan 2023STTK Shattuck LabsBiotechnologySEC FORM 4 Code A—34,925 at $0.00filing
10 Jan 2022filed 12 Jan 2022STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—66,650 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care6

Buys in green, sells in red, by the company’s sector.

Related people

Abhinav A. ShuklaChief Technical Officer · Chief Technical Officer at Shattuck Labs, filing Form 4 there in the last year
Arundathy N. PanditeChief Medical Officer · Chief Medical Officer at Shattuck Labs, filing Form 4 there in the last year
Mona AshiyaDirector · Director at Shattuck Labs, filing Form 4 there in the last year
ORBIMED ADVISORS LLCDirector and 10% owner · Director at Shattuck Labs, filing Form 4 there in the last year
Clay B. SiegallPresident and CEO · Director at Shattuck Labs, filing Form 4 there in the last year